Prestigious Prize Honors Pioneering Body's Defenses Discoveries

This year's prestigious award in Physiology or Medicine has been awarded for transformative findings that illuminate how the immune system targets harmful infections while protecting the healthy tissues.

A trio of renowned scientists—Japan's Shimon Sakaguchi and US experts Dr. Brunkow and Dr. Ramsdell—received this honor.

Their research uncovered specialized "security guards" within the defense system that eliminate malfunctioning defense cells capable of harming the organism.

The discoveries are now enabling innovative treatments for autoimmune diseases and malignancies.

The winners will divide a monetary award valued at 11 million SEK.

Crucial Findings

"The work has been essential for understanding how the body's defenses functions and why we don't all suffer from severe autoimmune diseases," stated the head of the Nobel Committee.

The trio's research address a core question: How does the defense system protect us from countless invaders while keeping our healthy cells unharmed?

The immune system employs immune cells that search for indicators of disease, including viruses and germs it has never encountered.

These defenders utilize sensors—known as receptors—that are produced by chance in a vast number of variations.

This provides the immune system the capacity to fight a wide array of invaders, but the unpredictability of the process unavoidably produces white blood cells that may attack the host.

Protectors of the Immune System

Scientists earlier knew that a portion of these harmful defense cells were eliminated in the thymus—where white blood cells develop.

The latest award recognizes the discovery of regulatory T-cells—described as the immune system's "peacekeepers"—which travel through the body to neutralize other defenders that attack the healthy cells.

It is known that this mechanism fails in autoimmune diseases such as juvenile diabetes, MS, and RA.

A Nobel panel stated, "These findings have laid the foundation for a new field of investigation and spurred the creation of new therapies, for example for tumors and autoimmune diseases."

Regarding malignancies, T-regs block the system from attacking the growth, so studies are focused on reducing their numbers.

For autoimmune diseases, trials are exploring boosting regulatory T-cells so the organism is not being harmed. A similar method could also be effective in reducing the risks of transplanted organ rejection.

Innovative Studies

Prof Sakaguchi, from a Japanese institution, conducted tests on rodents that had their thymus removed, leading to autoimmune disease.

He showed that injecting immune cells from healthy mice could stop the disease—implying there was a system for preventing immune cells from harming the body.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Dr. Ramsdell, now at a biotech firm in a California city, were studying an genetic immune disorder in rodents and people that resulted in the identification of a gene vital for how T-regs function.

"Their groundbreaking work has revealed how the body's defenses is kept in check by regulatory T cells, preventing it from accidentally attacking the healthy cells," said a leading biological science specialist.

"The research is a striking example of how fundamental physiological research can have broad implications for human health."